Blog
RSS FeedPosted by Michael Wonder on 30 Oct 2023
Switzerland restricts reimbursement of orphan drugs
30 October 2023 - New rules for the reimbursement of orphan drugs and other unlisted medicines will become effective in Switzerland ...
Posted by Michael Wonder on 10 Sep 2015
Santhera receives European marketing authorisation for Raxone in Leber's hereditary optic neuropathy (LHON)
9 September 2015 - Santhera Pharmaceuticals announces the European Commission (EC) has granted marketing authorisation for Raxone as the first approved ...
Posted by Michael Wonder on 01 Sep 2015
European Commission grants marketing authorisation for Strensiq (asfotase alfa) for the treatment of patients with paediatric-onset hypophosphatasia (HPP)
1 September 2015 - Alexion Pharmaceuticals, Inc. announced today that the European Commission has approved Strensiq (asfotase alfa) for long-term enzyme ...
Posted by Michael Wonder on 01 Sep 2015
European Commission grants marketing authorisation for Kanuma (sebelipase alfa) for the treatment of patients of all ages with lysosomal acid lipase deficiency (LAL-D)
1 September 2015 - Alexion Pharmaceuticals, Inc. announced today that the European Commission (EC) has approved Kanuma (sebelipase alfa) for long-term ...